Welcome to our dedicated page for Scansource SEC filings (Ticker: SCSC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Tracking ScanSource’s dual-segment distribution model through hundreds of pages can feel overwhelming. Gross profit spreads across point-of-sale hardware, barcode mobility, and fast-growing cloud subscriptions, making a single ScanSource annual report 10-K simplified hard to find. Stock Titan surfaces the numbers that matter—cash-cycle metrics, reseller credit exposure, and cloud ARR—so you can stop scrolling and start understanding.
Whether you need a ScanSource quarterly earnings report 10-Q filing, the latest ScanSource 8-K material events explained, or real-time alerts on ScanSource insider trading Form 4 transactions, our platform delivers every document the moment it hits EDGAR. Then our AI reads it for you. The result: concise explanations of segment revenue shifts, risk-factor changes, and inventory turns—ScanSource SEC filings explained simply.
- Instant push when a ScanSource Form 4 insider transactions real-time post shows an executive stock purchase
- Bullet-point highlights from each filing for fast ScanSource earnings report filing analysis
- Plain-English answers for "understanding ScanSource SEC documents with AI" so you can compare quarters in minutes
Dig deeper into the upcoming ScanSource proxy statement executive compensation to see how leadership incentives link to gross-profit dollars, or monitor a surprise contract disclosure via our AI summary of ScanSource 8-K material events explained. Whatever you search—ScanSource executive stock transactions Form 4 or segment-level profitability—Stock Titan keeps every filing organized, searchable, and clarified.
ScanSource, Inc. filed an 8-K/A confirming a planned change in independent auditors. The Audit Committee approved the transition after a competitive process on October 9, 2025. Grant Thornton LLP was dismissed effective November 6, 2025, immediately after the company filed its Form 10-Q for the quarter ended September 30, 2025. Deloitte & Touche LLP’s engagement began November 6, 2025 for the fiscal year ending June 30, 2026 and related interim periods commencing after September 30, 2025.
Grant Thornton’s audit reports for the fiscal years ended June 30, 2025 and June 30, 2024 contained no adverse opinion, disclaimer, or qualification as to uncertainty, audit scope, or accounting principles. The company reports no disagreements or reportable events with Grant Thornton through November 6, 2025. Grant Thornton’s concurrence letter is filed as Exhibit 16.1.
ScanSource, Inc. furnished an update on its first-quarter results for the period ended September 30, 2025. The company issued a press release and an earnings infographic, which are provided as Exhibits 99.1 and 99.2 and available on its website.
The materials are unaudited and are being furnished, not filed, under the Exchange Act. ScanSource also noted that an updated investor presentation will be posted on its website within approximately two weeks.
ScanSource (SCSC) reported Q1 FY2026 results for the quarter ended September 30, 2025. Net sales were $739.7 million (down 4.6% year over year), while net income rose to $19.9 million from $17.0 million. Diluted EPS was $0.89 versus $0.69 a year ago as improved margins and lower non-operating expenses offset lower revenue. Gross profit increased to $107.5 million, lifting gross margin to 14.5% from 13.1%.
By segment, Specialty Technology Solutions sales were $715.4 million (down 4.9%) with margin expansion to 11.7%, aided by favorable supplier program recognition and mix. Intelisys & Advisory sales were $24.2 million (up 4.0%), reflecting an acquisition; Intelisys net billings grew 1.7%. Operating income improved to $25.9 million from $17.6 million as prior-year restructuring did not recur. Cash from operations was $23.2 million; the company repurchased $21.3 million of stock. Total debt was $133.9 million with $350.0 million revolver availability, and the company was in covenant compliance. Subsequent event: acquisition of DataXoom on October 20, 2025.
ScanSource (SCSC) filed its annual report outlining a two-segment structure and steady scale. For the fiscal year ended June 30, 2025, net sales were $3.04 billion. Effective July 1, 2024, the company realigned to two operating segments: Specialty Technology Solutions (wholesale/resale model for hardware, SaaS and subscription services across mobility, POS, security, networking and communications) and Intelisys & Advisory (agency model distributing connectivity, cloud and next‑gen technologies and advisory services).
ScanSource serves ~25,000 channel sales partners with offerings from ~500 suppliers. Two suppliers—Cisco and Zebra—each represented more than 10% of fiscal 2025 net sales, highlighting supplier concentration risk. International operations contributed 7.9% of revenue, primarily in Brazil. The company reported approximately 2,100 employees, a central North American distribution center in Southaven, MS (741,000 sq. ft.), and continued investment in cybersecurity after a May 2023 ransomware incident. As of August 18, 2025, common shares outstanding were 21,884,508. The report details credit exposure, supply chain, competition and liquidity risks alongside a focus on operational excellence and partner enablement.
ScanSource, Inc. filed its definitive proxy for the 2025 Annual Meeting, outlining fiscal 2025 performance and governance items for shareholder vote. Net sales were just over $3 billion, down 6.7%, while gross profits rose to $408.6 million (up 2.4%) and adjusted EBITDA reached $144.7 million (up 2.8%). Gross margin improved to 13.4% and adjusted EBITDA margin to 4.76%. Non-GAAP net income was $85.1 million (up 9.6%) and free cash flow was $104 million, aided by $106.5 million in share repurchases. Recurring revenue contributed 32.8% of consolidated gross profits versus 27.5% last year; adjusted ROIC rose to 13.6%.
The company ended fiscal 2025 with $126 million in cash, $112.3 million in operating cash flow and $104.1 million in free cash flow. August 2024 acquisitions of Resourcive and Advantix were accretive to non-GAAP EPS and adjusted ROIC. The Annual Meeting is set for December 9, 2025 at 9:00 a.m. EST. Shareholders will vote to elect eight directors, approve NEO compensation on an advisory basis, and ratify Deloitte & Touche LLP as auditor for fiscal 2026 following a competitive process; Grant Thornton was dismissed after completing the Q1 FY2026 review. The record date is October 3, 2025 with 22,067,128 shares entitled to vote.
ScanSource, Inc. announced an auditor transition. Following a competitive process, the Audit Committee approved the dismissal of Grant Thornton LLP as independent registered public accounting firm, effective upon completion of the interim review of the Form 10-Q for the three months ended September 30, 2025. Grant Thornton was notified on October 10, 2025.
The Committee appointed Deloitte & Touche LLP as the new independent auditor for the fiscal year ending June 30, 2026 and related interim periods commencing after September 30, 2025, subject to completion of standard client acceptance procedures and an engagement letter. ScanSource reports that Grant Thornton’s audit opinions for fiscal 2024 and 2025 were unmodified and there were no disagreements or reportable events through October 9, 2025. Grant Thornton’s concurrence letter, dated October 16, 2025, is filed as Exhibit 16.1.
SCANSOURCE, INC. insider Michael L. Baur executed option exercises and share sales on September 17-18, 2025. The filing shows exercises of employee stock options at an exercise price of $38.19 for a total of 125,000 underlying shares (102,031 on 09/17 and 22,969 on 09/18), resulting in reported beneficial ownership of 250,481 shares after the 09/18 transactions. Concurrently, the reporting person sold 150,000 shares across two days at weighted-average prices of $44.96 and $44.34, reducing direct holdings to 202,512 shares after 09/18. The option grant vested in three annual installments beginning 12/04/2016.
ScanSource, Inc. (SCSC) reported a Form 144 notice for the proposed sale of 150,000 common shares, with an aggregate market value of $6,743,966.40, to be sold on or about 09/17/2025 through Merrill Lynch on the NASDAQ. The filing lists 21,884,508 shares outstanding, indicating the shares to be sold represent about 0.69% of outstanding stock.
All 150,000 shares were acquired from ScanSource, Inc. as compensatory awards: 2,618 and 122,382 shares from exercises dated 09/17/2025, and vested awards of 2,451 (08/26/2024), 14,872 (08/25/2025) and 7,677 (08/26/2025). The filer states no sales by the person in the prior three months and certifies no undisclosed material adverse information.
This Schedule 13G/A relates to ScanSource, Inc. (ticker SCSC) and reports filings by Alma Consulting & Investments S.L. and its sole administrator, Orlando Alonso Villaron. Both reporting persons declare zero shares beneficially owned and therefore 0.0% of the class. The filing lists the issuer's principal executive office in Greenville, South Carolina, and gives the reporting persons' address in Madrid, Spain. The statement certifies the securities were not acquired to influence control of the issuer and provides signatures dated 09/11/2025.
Ford Brandy, SVP & Chief Accounting Officer of ScanSource, Inc. (SCSC), reported equity changes tied to restricted stock unit vesting. The filing shows an initial non-market tax-withholding disposition of 239 shares on 08/30/2025 and a further withholding of 119 shares on 09/01/2025, both at a reported per-share value of $43.65. On 09/01/2025 the reporting person acquired 4,616 shares (vested restricted stock units) at $0.00 acquisition price for reporting purposes. Following these transactions, the reporting person beneficially owned 12,986 shares directly. The form is signed by an attorney-in-fact, J. Creighton Lynes, dated 09/03/2025. The filer explains the dispositions were shares withheld to satisfy tax withholding obligations and are non-market transactions.